This is the authors' abstract. We don't add key points for this paper.
• Allogeneic MSCs are safety to be transplanted by subconjunctival route. • Allogeneic MSCs therapy seems to be efficient in improving corneal healing in dogs. • Allogeneic MSCs therapy applied to depth corneal ulcers promoted healing in 14 days. • The paracrine effect of MSCs must provide a rapid corneal wound healing.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Falcão et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: